Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas
- PMID: 62792
Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas
Abstract
The purification of a blocking factor from the sera of tumor-bearing mice is described. Whole serum with blocking activity-the ability to inhibit specific cell-mediated anti-tumor immunity in microcytotoxicity tests-was fractionated on immunoadsorbent columns containing Sepharose-bound syngeneic normal mouse immunoglobulins and immunoglobulins from tumor-immune donors. The blocking serum was derived from mice which had carried a transplanted methylocholanthrene-induced sarcoma for 21 to 28 days. Elution of the immunoadsorbents recovered the blocking activity in a single fraction. This fraction was blocking activity in a single fraction. This fraction was radiolabeled and analyzed by SDS gel electrophoresis and Sephadex G-200 column chromatography. The active component of the blocking serum was shown to be a polypeptide of m.w. 56,000. Specificity testing implied that the factor was likely to be either tumor antigen or an antigen-specific suppressor molecule.
Similar articles
-
Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.J Immunol. 1976 Mar;116(3):724-30. J Immunol. 1976. PMID: 1254951
-
Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.J Immunol. 1985 Mar;134(3):1665-72. J Immunol. 1985. PMID: 2578515
-
Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.J Natl Cancer Inst. 1982 Oct;69(4):939-44. J Natl Cancer Inst. 1982. PMID: 6750199
-
Suppressor cell activity in tumor-bearing mice. III. Co-purification of a factor inhibiting cellular DNA synthesis and DNA polymerase activity.J Immunol. 1981 Dec;127(6):2339-44. J Immunol. 1981. PMID: 6457873
-
[Biochemical characterization of tumor rejection antigen (TRA) and genetic control in anti-TRA immune responses].Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 2):646-52. Gan To Kagaku Ryoho. 1989. PMID: 2468311 Review. Japanese.
Cited by
-
Suppressor mechanisms in tumor immunity.Experientia. 1983 Mar 15;39(3):235-42. doi: 10.1007/BF01955286. Experientia. 1983. PMID: 6186519 Review.
-
Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.Cancer Immunol Immunother. 1982;14(2):124-31. doi: 10.1007/BF00200180. Cancer Immunol Immunother. 1982. PMID: 6965227 Free PMC article.
-
Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors.Proc Natl Acad Sci U S A. 1977 Oct;74(10):4605-9. doi: 10.1073/pnas.74.10.4605. Proc Natl Acad Sci U S A. 1977. PMID: 73182 Free PMC article.
-
[Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].Klin Wochenschr. 1980 Feb 1;58(3):125-33. doi: 10.1007/BF01477269. Klin Wochenschr. 1980. PMID: 7366126 German.
-
Selective suppression of the generation of anti-tumor L3T4+ but not of Lyt-2+ T cell-mediated immunity in the tumor-bearing state.Jpn J Cancer Res. 1988 Jul;79(7):857-65. doi: 10.1111/j.1349-7006.1988.tb00048.x. Jpn J Cancer Res. 1988. PMID: 3139599 Free PMC article.